Table 3.
Characteristics of IATS before and during COVID-19 pandemic
| Before COVID-19 pandemic (n=30) |
During COVID-19 pandemic (n=40) |
|
| WHO region | ||
| African Region (AFRO) | 1 (3.3%) | 9 (22.5%) |
| Region of the Americas (AMRO) | 5 (16.7%) | 5 (12.5%) |
| Eastern Mediterranean Region (EMRO) | 0 (0.0%) | 2 (5.0%) |
| European Region (EURO) | 4 (13.3%) | 9 (22.5%) |
| South-East Asia Region (SEARO) | 0 (0.0%) | 2 (5.0%) |
| Western Pacific Region (WPRO) | 20 (66.7%) | 13 (32.5%) |
| HICs and LMICs | ||
| HICs | 29 (96.7%) | 27 (67.5%) |
| LMICs | 1 (3.3%) | 13 (32.5%) |
| Sample size | ||
| Minimum | 28 | 11 |
| Maximum | 12 965 | 31 332 |
| Median | 1050 | 412.5 |
| Mean | 2231.3 | 2518 |
| Study design | ||
| Qualitative | 2 (6.7%) | 13 (32.5%) |
| Quantitative randomised controlled trials | 0 (0.0%) | 1 (2.5%) |
| Quantitative non-randomised | 8 (26.7%) | 8 (20.0%) |
| Quantitative descriptive | 20 (66.7%) | 15 (37.5%) |
| Mixed methods | 0 (0.0%) | 3 (7.5%) |
| Scale | ||
| International | 0 (0.0%) | 1 (2.5%) |
| National | 2 (6.7%) | 10 (25.0%) |
| Regional | 11 (36.7%) | 11 (27.5%) |
| Local | 17 (56.7%) | 18 (45.0%) |
| Population | ||
| Adult individuals | 21 (70.0%) | 13 (32.5%) |
| Households | 6 (20.0%) | 1 (2.5%) |
| HCPs | 0 (0.0%) | 7 (17.5%) |
| Patients | 0 (0.0%) | 10 (25.0%) |
| Other | 3 (10.0%) | 9 (22.5%) |
| Phone type | ||
| Landline | 20 (66.7%) | 1 (2.5%) |
| Mobile | 1 (3.3%) | 10 (25.0%) |
| 50–50 | 1 (3.3%) | 2 (5.0%) |
| Not specified | 8 (26.7%) | 27 (67.5%) |
HCPs, healthcare professionals; HICs, high-income countries; IATS, interviewer-administered telephone surveys; LMICs, low-income and middle-income countries.